Navigation Links
arGEN-X Starts Phase Ib Expansion Cohorts With ARGX-110, a Novel Anti-CD70 Antibody, in Cancer Patients
Date:1/13/2014

>

About the ARGX-110 Study

The Phase Ib study (ClinicalTrials.gov Identifier: NCT01813539) consists of a dose escalation phase followed by adaptive safety and efficacy expansion cohorts conducted in patients with advanced, refractory cancer. The patient enrichment strategy relies on individual tumor screening for CD70 utilizing a reproducible immunohistochemistry method. In addition to traditional clinical and PK/PD endpoints, biomarkers documenting the three modes of action of ARGX-110 are being evaluated. Patient enrolment is planned at approximately 90 CD70-positive patients with either haematological or solid tumors. The study is managed jointly by arGEN-X and a consortium of leading academic institutions in Belgium.

About arGEN-X

arGEN-X is a clinical stage human therapeutic antibody company that is rapidly developing a product pipeline using its unique suite of antibody technologies. arGEN-X is creating first and best in class antibody therapeutics with highly differentiated target product profiles. Its therapeutic antibody programs, focused on cancer and autoimmune indications, are designed to deliver tangible benefits to patients with these diseases.

http://www.argen-x.com

About IWT

The agency for Innovation by Science and Technology (abbreviated as IWT) is the government agency founded in 1991 by the Flemish Government to support technological innovation projects in Flanders. Each year IWT distributes about EUR 300 million in subsidies for innovation projects to companies, organizations, research and educational institutions in Flanders. In addition to financial support, IWT also assists companies by, for instance helping them find the right information or the right partners at home or abroad, providing assistance with the preparation of projects for European programmes and with technology transfer throughout Europe. IWT
'/>"/>

SOURCE arGEN-X
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. arGEN-X Appoints Dr. David L. Lacey to its Supervisory Board
2. arGEN-X Announces Preclinical Development of ARGX-112 for Dermatology
3. arGEN-X Identifies Potent Antibody Antagonists against Complex Chronic Pain Target Nav1.7
4. arGEN-X Initiates Phase IbStudy of ARGX-111 in Cancer
5. arGEN-X raises EUR 5 Million from PMV in Extension of EUR 32.5 Million Series B
6. Russian Government Starts Using Scopus for National Research Assessment
7. John Daly, Previous Merck Exec., Starts CTW Consulting Firm
8. FDA starts process to cut back antibiotic overuse in livestock
9. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
10. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
11. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... , Feb. 27, 2015 Pharmaceutical and biotech ... multiple products for the same indication. This can be ... want to prevent one of their brands from gaining ... According to recent research by benchmarking firm, Best Practices, ... independent brands rather than together as part of a ...
(Date:2/27/2015)... 2015  Pomerantz LLP is investigating claims on behalf ... "Company") (NASDAQ: VTAE ).  Such investors are ... rswilloughby@pomlaw.com or 888-476-6529, ext. 237. ... officers and/or directors have violated Sections 10(b) and 20(a) ... On February 27, 2015, the Company announced that ...
(Date:2/27/2015)... 2015  Following a bipartisan vote in the ... 284, the Medicare DMEPOS Competitive Bidding Improvement Act ... (AAHomecare) released a statement praising the Committee,s work ... legislation. "Today,s mark-up of the Competitive ... Means Committee is a critical step forward for ...
Breaking Medicine Technology:New Report Details How to Expand a Pharmaceutical Product Portfolio without Cannibalizing an Established Brand 2SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vitae Pharmaceuticals, Inc. - VTAE 2Bidding Fix Takes Major Step Forward After Bipartisan Vote of House Ways and Means Committee 2
... PharmaTech (Cayman) Inc. (NYSE: WX ), a ... with operations in China and the United States, today ... second quarter of 2011 after the New York Stock ... be Thursday morning, August 11, 2011 Shanghai time). The ...
... RAPIDS, Mich., July 19, 2011 ... rehabilitation and software services that benefit patients, healthcare ... to its multi-state group of outpatient clinics.  Agility ... the Company,s Michigan-based outpatient clinic presence to 23 ...
Cached Medicine Technology:WuXi PharmaTech Schedules Second-Quarter 2011 Earnings Release 2Agility Health Expands National Outpatient Clinic Group with New Michigan Facility 2
(Date:3/1/2015)... CrossFit Attollo is a CrossFit gym located in Vancouver ... to new members. Now through the end of March ... will receive their fourth month half off. , ... The three month contract is only $264, dropping the price ... comes in at only $55. The special saves new members ...
(Date:2/28/2015)... 2015 In a recent episode of ... Game Change Athlete Development Services and Consultancy ... benefits of athlete development and player engagement during and ... challenges that athletes face and how off-field activities are ... Fletcher became involved in athlete development issues while in ...
(Date:2/28/2015)... Portland, Oregon (PRWEB) February 28, 2015 ... Portland, Oregon, is offering a new special. Throughout ... denture relines. , This service ... from sleep problems and pain. Patients may notice certain ... and need relining. These symptoms include: , 1.    Pain, ...
(Date:2/28/2015)... Indosoft Inc , developers of ... are pleased to announce the development of Q-Suite 5.9. ... versions of Q-Suite, this new version will include enhancements ... new features to the leading edge call center software. ... will add features to enhance security and protection. Administrators ...
(Date:2/28/2015)... Pioneer Millworks reclaimed USA wood will be ... Materials Show, an annual, premier sustainable building event in ... top manufacturers of the latest building products, services and ... and manufactured by Pioneer Millworks from their Oregon and ... restaurants, hotels, retailers, and corporate offices. Nichibi Global ...
Breaking Medicine News(10 mins):Health News:CrossFit Gym in Vancouver WA Offers Spring Special 2Health News:SCI TV Covers Athlete Development with Duncan Fletcher 2Health News:SCI TV Covers Athlete Development with Duncan Fletcher 3Health News:Classic Denture Center in Portland Oregon is Offering March Discount 2Health News:Indosoft Proudly Announces Q-Suite 5.9 Call Center Software for Asterisk 2Health News:US Reclaimed Wood from Pioneer Millworks to be Featured at Architecture & Construction Materials Show in Tokyo. 2
... fire at Moscow drug rehabilitation clinic no. 17,faced one of the ... the last three decades //. 45 women were killed because of ... addicts below the age of 35.Some were HIV patients and few ... in fact warned a few months ago that the building ...
... Model developed with the systems biology approach may lead ... the researchers //at University of Montreal. ,Montreal ... Johns Hopkins University have made a major breakthrough in ... ,For the first time, using a systems ...
... Disorder suffer through a range of problems, from poor ... more than half of these children also have serious ... never learning to develop the social skills they need ... ,“Children with ADHD often are peer-rejected, and their difficulties ...
... a pre-kindergarten, families often have to forego considerations of ... school-home collaboration and provisions such as meals. // ... the FPG Child Development Institute at the University of ... of children in publicly funded pre-kindergarten (pre-K) programs define ...
... initiate a general discussion about the need for antidepressant ... to be thoroughly evaluated for depression than those who ... a new study in the December issue of Medical ... requests for antidepressants increased the likelihood that patients would ...
... agreement to support a $ 500 million research to further stem ... decision to legalise stem cell research, being only the second state ... million has already garnered enough support to gain the approval of ... M Cohen from D-Union who is one of the bills co-sponsors. ...
Cached Medicine News:Health News:Montreal Researchers And US Develop Model Of Key Immune-System Component 2Health News:Montreal Researchers And US Develop Model Of Key Immune-System Component 3Health News:Friendship Clinic: Psychologist Helps Children With ADHD Make Friends 2Health News:Friendship Clinic: Psychologist Helps Children With ADHD Make Friends 3Health News:Families Need More Than Quality Education from Pre-K Programs 2Health News:Patients' Requests for Antidepressants can Influence Physician Evaluation of Depression 2Health News:Patients' Requests for Antidepressants can Influence Physician Evaluation of Depression 3Health News:New Jersey Decides to Support $500 M Stem Cell Research 2
CDIs 2nd Stage Abdominoplasty Girdle - a feminine, easy pull-on version of the 8000 series...
... a smoother fit in the abdominal area ... padded continuous hook and eye closures extend ... extra strong, yet very thin zipper opens ... reinforced open crotch, gripper lace trim, and ...
For lipoplasty of trochanteric area, abdomen, thighs, hips, buttocks and flanks...
Below Knee Girdle, High Waist...
Medicine Products: